INHBE-3
Asset
GalNAc-conjugated siRNA silences hepatic INHBE, lowering Activin E and modulating adipocyte lipolysis.
- Stage
- Preclinical
- Modality
- Oligonucleotide
- Target
- Lipid and ceramide metabolism
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Obesity
Preclinical, doi.org, 5 Jun 2026
In the full profile
- Targets and what it contains3
- Owner and partners1
- Evidence for its targets4
- Competitors12
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.